Statements (59)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
7
|
| gptkbp:bfsParent |
gptkb:Digoxin
|
| gptkbp:analyzes |
drug interactions
|
| gptkbp:appointed_by |
oral tablet
intravenous injection monitoring of heart rhythm |
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:brand |
gptkb:Quinaglute
Cardioquin |
| gptkbp:can_be_used_with |
other antiarrhythmic drugs
|
| gptkbp:composed_of |
natural sources
|
| gptkbp:contraindication |
gptkb:Insurance_Company
complete heart block hypersensitivity to quinidine |
| gptkbp:developed_by |
cinchona bark
|
| gptkbp:discontinued |
1950s
|
| gptkbp:has_influence_on |
sodium channel blocker
|
| https://www.w3.org/2000/01/rdf-schema#label |
Quinidine
|
| gptkbp:ingredients |
C20 H24 N2 O2
|
| gptkbp:is_analyzed_in |
cardiac arrhythmias
|
| gptkbp:is_associated_with |
QT interval prolongation
|
| gptkbp:is_available_in |
tablet form
injectable form |
| gptkbp:is_available_on |
generic medication
|
| gptkbp:is_considered |
a class 1a antiarrhythmic agent
a critical medication in cardiology a second-line treatment option |
| gptkbp:is_evaluated_by |
its safety profile
|
| gptkbp:is_known_for |
its bitter taste
|
| gptkbp:is_part_of |
pharmacological studies
quinoline alkaloids treatment guidelines for atrial fibrillation treatment protocols for arrhythmias |
| gptkbp:is_related_to |
quinine
|
| gptkbp:is_studied_in |
its efficacy in arrhythmias
|
| gptkbp:is_subject_to |
regulatory approval
|
| gptkbp:is_used_for |
treating atrial fibrillation
treating ventricular tachycardia |
| gptkbp:is_used_in |
cardiology
clinical trials emergency medicine palliative care for certain conditions |
| gptkbp:lifespan |
6 to 8 hours
|
| gptkbp:metabolism |
liver
|
| gptkbp:relationship |
gptkb:digoxin
gptkb:warfarin antacids |
| gptkbp:side_effect |
dizziness
headache nausea diarrhea |
| gptkbp:suitable_for |
pregnant women
breastfeeding women patients with liver disease patients with renal impairment patients with a history of syncope |
| gptkbp:treatment |
malaria
|
| gptkbp:weight |
324.42 g/mol
|